KR0173084B1 - Method for the purification of triamine compound - Google Patents
Method for the purification of triamine compound Download PDFInfo
- Publication number
- KR0173084B1 KR0173084B1 KR1019960010835A KR19960010835A KR0173084B1 KR 0173084 B1 KR0173084 B1 KR 0173084B1 KR 1019960010835 A KR1019960010835 A KR 1019960010835A KR 19960010835 A KR19960010835 A KR 19960010835A KR 0173084 B1 KR0173084 B1 KR 0173084B1
- Authority
- KR
- South Korea
- Prior art keywords
- purification
- toluene
- inorganic salt
- sodium
- structural formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/82—Purification; Separation; Stabilisation; Use of additives
- C07C209/84—Purification
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
본 발명은 하기 구조식(Ⅰ)로 표시되는 1,17-디아미노-9-아자헵타데칸의 정제 방법에 관한 것이다.The present invention relates to a method for purifying 1,17-diamino-9-azaheptadecane represented by the following structural formula (I).
Description
본 발명은 트리아민 화합물의 정제 방법에 관한 것으로, 보다 구체적으로는 하기 구조식(Ⅰ)로 표시되는 1,17-디아미노-9-아자헵타데칸의 정제 방법에 관한 것이다.The present invention relates to a method for purifying a triamine compound, and more particularly, to a method for purifying 1,17-diamino-9-azaheptadecane represented by the following structural formula (I).
상기 구조식(Ⅰ)의 화합물은 사과의 검은 별무늬병, 포도의 회색 곰팡이병, 복숭아의 잿빛 무늬병 등의 방제에 유용한 살균제로 잘 알려진 하기 구조식(Ⅱ)로 표기되는 1,1`-아미노디(옥타메틸렌)디구아니디움 트리아세테이트의 합성 중간체로서, 하기 구조식(Ⅲ)으로 표시되는 옥타메틸렌디아민을 산촉매하에서 반응시켜 제조된다.The compound of formula (I) is 1,1`-aminodi represented by the following structural formula (II), which is well known as a fungicide useful for controlling black star pattern disease of apples, gray mold disease of grapes, gray ash pattern of peach, etc. As a synthetic intermediate of octamethylene) diguanidium triacetate, it is prepared by reacting octamethylenediamine represented by the following structural formula (III) under an acid catalyst.
그런데 이 반응은 구조식(Ⅲ)의 아량체인 구조식(Ⅰ)뿐만 아니라 삼량체인 하기 구조식(Ⅳ)를 포함한 다른 부생성물도 생성되기 때문에 구조식(Ⅰ)의 정제 방법은 매우 중요하다.However, since the reaction generates not only Structural Formula (I), which is a submer of Structural Formula (III), but also other by-products including the following Structural Formula (IV), which is a trimer, the purification method of Structural Formula (I) is very important.
예컨대, 유럽 특허공고 제013554호에는 상기 구조식(Ⅰ)의 화합물은 감압증류로 정제되고 있으나, 이의 끓는점과 녹는점이 높기 때문에 증류할 때 높은 온도와 고진공이 필요하고, 여타의 문제점을 수반하고 있어 공업적인 방법으로서는 미흡한 점이 많다.For example, in European Patent Publication No. 013554, the compound of formula (I) is purified by distillation under reduced pressure, but since its boiling point and melting point are high, distillation requires high temperature and high vacuum, and it is accompanied by other problems. There are many inadequate methods.
즉, 상기 특허공고의 정제 방법 중 하나는 구조식(Ⅰ)화합물의 높은 끓는점 때문에 190~220℃의 온도, 4mmHg의 압력에서 구조식(Ⅰ)의 화합물을 고온 감압증류하여 정제하기 때문에 고진공장치와 고온 반응기 장치가 필요하고, 또한 구조식(Ⅰ)의 화합물의 높은 녹는점 때문에 증류관 및 여러 설비의 보온 장치가 필요한 단점이 있다.That is, one of the methods for purifying the patent publication is a high vacuum apparatus and a high temperature reactor because the high boiling point of the compound of formula (I) is purified by distillation of the compound of formula (I) at high temperature under reduced pressure at a temperature of 190-220 ° C. and a pressure of 4 mmHg. An apparatus is required, and due to the high melting point of the compound of formula (I), a distillation tube and a thermostat of various equipment are required.
이에 본 발명자들은 전술한 공지의 방법에 따른 문제점을 해결하고 보다 적합한 정제방법을 찾기 위하여 연구를 하던 중, 유기용매 하에서 용해도 차이와 일반적으로 사용되는 무기염을 이용하여 목적화합물을 높은 수율로 제조할 수 있다는 놀라운 사실을 밝혀내고 본 발명을 완성하게 되었다.Therefore, the present inventors have been researching to solve the problems according to the above-mentioned known methods and to find a more suitable purification method, and to prepare the target compound in high yield using the difference in solubility and the inorganic salts generally used in organic solvents. It has been found that the surprising fact that it can be completed to complete the present invention.
본 발명은 불순한 트리아민(트리/테트라=80/20)을 톨루엔에 가하고 가열하여 완전히 용해시킨 후, 무기염을 가하고, 생성된 테트라민 고체를 여과에 의해 제거하여 하기 구조식(Ⅰ)의 1,17-디아미노-9-아자헵타데칸을 정제하는 방법에 관한 것이다.In the present invention, impure triamine (tri / tetra = 80/20) is added to toluene, heated to completely dissolve it, and then an inorganic salt is added, and the resulting tetramine solid is removed by filtration to obtain 1, the following structural formula (I). A method for purifying 17-diamino-9-azaheptadecane.
이하 본 발명의 정제방법을 상세히 설명한다.Hereinafter, the purification method of the present invention will be described in detail.
본 발명은 하기 구조식(Ⅰ)로 표기되는 트리아민의 정제방법을 유기용매의 용해도 차이와 불순물의 결정성을 돕는 일반적인 무기염을 이용한다.The present invention utilizes a general inorganic salt which helps the triamine represented by the following structural formula (I) to assist in the solubility difference of the organic solvent and the crystallinity of impurities.
불순한 트리아민(트리/테트라=80/20)을 적당량의 톨루엔에 넣고 가열하여 완전히 용해시키고, 서서히 냉각시켜 생성된 불순물(테트라)을 여과하여 제거한다.Impure triamine (tri / tetra = 80/20) is placed in an appropriate amount of toluene, heated to complete dissolution, and gradually cooled to remove impurities (tetra) produced by filtration.
이 때 일반적인 무기염을 첨가하여 불순물의 결정화를 높이는 촉매로 사용한다.At this time, it is used as a catalyst to increase the crystallization of impurities by adding a general inorganic salt.
본 발명에 따른 유기용매로는 톨루엔이 사용되며 톨루엔의 양은 정제전 하기식(Ⅰ)과의 혼합물을 기준으로 하여 4~10배의 중량비로 사용하며, 바람직하게는 5~7배의 중량비로 사용한다.Toluene is used as the organic solvent according to the present invention, and the amount of toluene is used in a weight ratio of 4 to 10 times based on the mixture with the following formula (I) before purification, preferably in a weight ratio of 5 to 7 times. do.
무기염은 염화나트륨, 브롬화나트륨, 질산나트륨, 탄산나트륨, 황산나트륨, 염화나트륨, 염화칼륨 등이 사용될 수 있으나, 특히 좋기로는 염화나트륨 또는 질산나트륨이 바람직하다. 사용되는 무기염의 양은 유기용매의 0.3~3.0%로 하며 바람직하게는 0.5~1.5%로 한다.The inorganic salt may be sodium chloride, sodium bromide, sodium nitrate, sodium carbonate, sodium sulfate, sodium chloride, potassium chloride and the like, but sodium chloride or sodium nitrate is particularly preferred. The amount of the inorganic salt used is 0.3 to 3.0% of the organic solvent, preferably 0.5 to 1.5%.
정제는 20~40℃의 온도 범위에서 수행될 수 있으나, 바람직하게는 25~35℃에서 수행하는 것이 바람직하다.Purification may be carried out in a temperature range of 20 ~ 40 ℃, preferably, it is carried out at 25 ~ 35 ℃.
이하, 본 발명을 실시예에 의거 보다 구체적으로 설명한다.Hereinafter, the present invention will be described in more detail with reference to Examples.
[실시예 1]Example 1
트리아민(Ⅰ) 및 테트라민(Ⅳ)혼합물로 부터 순수 트리아민(Ⅰ)의 정제Purification of Pure Triamine (I) from Triamine (I) and Tetramin (IV) Mixtures
톨루엔 150g에 1,17-디아미노-9-아자헵타데칸이 80% 포함되고 구조식(Ⅳ)를 포함한 부성분이 20% 함유된 혼합물 25g을 넣고 교반하면서 온도를 90℃까지 승온하여 용해시킨다. 여기에 염화나트륨 1.0g을 투입하고 30분간 교반한 뒤 온도를 30℃까지 4시간동안 서서히 냉각한다.150 g of toluene was added to 25 g of a mixture containing 80% of 1,17-diamino-9-azaheptadecane and 20% of the subcomponent including Structural Formula (IV). 1.0 g of sodium chloride was added thereto, stirred for 30 minutes, and then slowly cooled to 4 DEG C for 30 hours.
이때 구조식(Ⅳ) 화합물과 다른 부성분이 고체화 되는 것을 확인하고 1시간동안 더 교반한다. 생성된 고체를 여과하여 여과액 톨루엔을 증류하고 목적화합물 19.1g을 흰색 결정으로 얻었다.(수득율:95.5%, 가스크로마토그래피 순도:95.4%)At this time, confirm that the compound of the structural formula (IV) and the other minor components are solidified, and further stirred for 1 hour. The resulting solid was filtered to distill the filtrate toluene to obtain 19.1 g of the target compound as white crystals (yield: 95.5%, gas chromatography purity: 95.4%).
[실시예 2]Example 2
트리아민(Ⅰ) 및 테트라민(Ⅳ)혼합물로 부터 순수 트리아민(Ⅰ)의 정제Purification of Pure Triamine (I) from Triamine (I) and Tetramin (IV) Mixtures
실시예1)과 같은 방법으로 정제하고, 염화나트륨 대신 질산나트륨 1.0g을 사용하여 목적화합물 19.2g을 흰색 결정으로 얻었다.(수득율:96.1%, 가스크로마토그래피 순도:95.8%)Purification was carried out in the same manner as in Example 1, and 1.0 g of sodium nitrate was used instead of sodium chloride to obtain 19.2 g of the target compound as white crystals (yield: 96.1%, gas chromatography purity: 95.8%).
[실시예 3]Example 3
트리아민(Ⅰ) 및 테트라민(Ⅳ)혼합물로 부터 순수 트리아민(Ⅰ)의 정제Purification of Pure Triamine (I) from Triamine (I) and Tetramin (IV) Mixtures
톨루엔 150g에 1,17-디아미노-9-아자헵타데칸이 70% 포함되고 구조식(Ⅳ)를 포함한 부성분이 30% 함유된 혼합물 25g을 넣고 실시예 1)과 같은 방법으로 정제하여 목적화합물 1,17-디아미노-9-아자헵타데칸 16.5g을 흰색 결정으로 얻었다.(수득율:94.3%, 가스크로마토그래피 순도:94.8%)150 g of toluene contains 70 g of 1,17-diamino-9-azaheptadecane and 30 g of a mixture containing 30% of the minor components including Structural Formula (IV), followed by purification in the same manner as in Example 1). 16.5 g of 17-diamino-9-azaheptadecane was obtained as white crystals. (Yield: 94.3%, gas chromatography purity: 94.8%)
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019960010835A KR0173084B1 (en) | 1996-04-10 | 1996-04-10 | Method for the purification of triamine compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019960010835A KR0173084B1 (en) | 1996-04-10 | 1996-04-10 | Method for the purification of triamine compound |
Publications (2)
Publication Number | Publication Date |
---|---|
KR970069976A KR970069976A (en) | 1997-11-07 |
KR0173084B1 true KR0173084B1 (en) | 1999-03-30 |
Family
ID=19455467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019960010835A KR0173084B1 (en) | 1996-04-10 | 1996-04-10 | Method for the purification of triamine compound |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR0173084B1 (en) |
-
1996
- 1996-04-10 KR KR1019960010835A patent/KR0173084B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR970069976A (en) | 1997-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5936104A (en) | Process for producing 1,2-epoxy-3-amino-4-phenylbutane derivatives | |
US2528267A (en) | Eobeet j | |
HU189641B (en) | Process for preparing l-ascorbic acid | |
US6197998B1 (en) | Process for producing N-glycyltyrosine and its crystal structure | |
US6143903A (en) | Process for the production of enantiomerically-pure azetidine-2-carboxylic acid | |
KR0173084B1 (en) | Method for the purification of triamine compound | |
EP0155779B1 (en) | A method for the optical purification of an optically active 2,2-dimethylcyclopropanecarboxylic acid amide | |
US5155257A (en) | Process for the preparation of acylaminomethanephosphonic acids | |
US3933902A (en) | Method for the optical resolution of DL-αphenylglycine | |
US3983162A (en) | Optical resolution of alkyl esters of DL-phenylalanine | |
JPH0737440B2 (en) | Method for producing sulfonium compound | |
GB2109369A (en) | Process for purifying guanine | |
US6147215A (en) | Process for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof | |
US5091540A (en) | Process for preparing clotrimazole | |
CA2280381C (en) | Improved process for the production of an n-acyl derivative of o,s-dialkyl phosphoroamidothioate | |
JP2507505B2 (en) | New method for producing cephalosporin derivatives | |
US3591579A (en) | Resolution of amino-caprolactams | |
EP0179487B1 (en) | 2-phenylpropionic acid esters, method for optical resolution thereof and optically active substance thereof | |
US4211883A (en) | Process for the production of p-(N-methyl)-aminobenzoyl-L-glutamic acid | |
EP0051956B1 (en) | Preparation of l-aspartic acid n-thiocarboxyanhydride | |
JP3815064B2 (en) | Method for purifying 1- (4-chlorobenzoyl) -5-methoxy-2-methylindole-3-acetic acid | |
JPH0948789A (en) | Purification of o,s-dimethyl-n-acetylphosphoramidothioate | |
JPH0446175A (en) | Production of 5-hydroxy-3,4-methylenedioxybenzoic acid derivative | |
JP2773627B2 (en) | Process for producing O, O'-diacyltartaric anhydride | |
JP2001322981A (en) | Method for producing n,n'-carbonylbislactam |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20060915 Year of fee payment: 9 |
|
LAPS | Lapse due to unpaid annual fee |